Hypertensive Disorders

  • Kurt Benirschke
  • Peter Kaufmann


Preeclampsia, a common disease of pregnancy, is now most frequently referred to as “pregnancy-induced hypertension” (PIH). The terms are interchangeable. A reason to be specific about the terminology is that the disease process may produce symptoms similar to those of “circulating lupus anticoagulant” (see Chapter 23). Moreover, to our veterinary colleagues, toxemia denotes a different disorder, usually a condition of ruminants. In fact, classical PIH is uncommon in animals. It has there been diagnosed primarily in primates, especially in patas monkeys (Gille et al., 1977; Palmer et al., 1979), but its effects are seen in other primate species, such as the gorilla, chimpanzee, and langur. Chesley (1985), a master of this disease, is adamant that strict criteria be used for its definition. He asserted that many patients with mild preeclampsia later suffer eclampsia.


Hypertensive Disorder Severe Preeclampsia Fetal Growth Retardation Preeclamptic Patient Villous Tissue 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abdella, T.N., Sibai, B.M., Hays, J.M., and Anderson, G.D.: Relationship of hypertensive disease to abruptio placentae. Obstet. Gynecol. 63:365–370, 1984.PubMedGoogle Scholar
  2. Abitbol, M.M., Driscoll, S.G., and Ober, W.B.: Placental lesions in experimental toxemia in the rabbit. Am. J. Obstet. Gynecol. 125:942–948, 1976a.PubMedGoogle Scholar
  3. Abitbol, M.M., Gallo, G.R., Pirani, C.L., and Ober, W.B.: Production of experimental toxemia in the pregnant rabbit. Am. J. Obstet. Gynecol. 124:460–470, 1976b.PubMedGoogle Scholar
  4. Abitbol, M.M., Pirani, C.L., Ober, W.B., Driscoll, S.G., and Cohen, M.W.: Production of experimental toxemia in the pregnant dog. Obstet. Gynecol. 48: 537–548, 1976c.PubMedGoogle Scholar
  5. Abitbol, M.M., Ober, W.B., Gallo, G.R., Driscoll, S.G., and Pirani, C.L.: Experimental toxemia of pregnancy in the monkey, with a preliminary report on renin and aldosterone. Am. J. Pathol. 86:573–590, 1977.PubMedGoogle Scholar
  6. Aladjem, S.: The syncytial knot: a sign of active syncytial proliferation. Am. J. Obstet. Gynecol. 99:350–358, 1967.PubMedGoogle Scholar
  7. Aladjem, S., Lueck, J., and Brewer, J.I.: Experimental induction of a toxemia-like syndrome in the pregnant beagle. Am. J. Obstet. Gynecol. 145:27–38, 1983.PubMedGoogle Scholar
  8. Alanen, A., Kekomäki, R., Kero, P., Lindström, P., and Wager, O.: Circulating immune complexes in hypertensive disorders of pregnancy. J. Reprod. Immunol. 6:133–140, 1984.PubMedCrossRefGoogle Scholar
  9. Alvarez, H.: Prolifération du trophoblaste et sa relation avec l’hypertension artérielle de la toxémie gravidique. Gynecol. Obstet. (Paris) 69:581–588, 1970.Google Scholar
  10. Alvarez, H., Benedetti, W.L., and DeLeons, V.K.: Syncytial proliferation in normal and toxemic pregnancies. Obstet. Gynecol. 29:637–643, 1967.PubMedGoogle Scholar
  11. Alvarez, H., Morel, R.L., Benedetti, W.L., and Scavarelli, M.: Trophoblast hyperplasia and maternal arterial pressure at term. Am. J. Obstet. Gynecol. 105:1015–1021, 1969.PubMedGoogle Scholar
  12. Anderson, W.R., and McKay, D.G.: Electron microscope study of the trophoblast in normal and toxemic placentas. Am. J. Obstet. Gynecol. 95:1134–1148, 1966.PubMedGoogle Scholar
  13. Anonymous: Pregnancy and the arachidonic-acid cascade. Lancet 1:997–998, 1982.Google Scholar
  14. Anonymous: Classification of hypertensive disorders of pregnancy. Lancet 1:935–936, 1989.Google Scholar
  15. Anunciado, A.N., Stubbs, T.M., Pepkowitz, S.H., Lazarchick, J., Miller III, C.M., and Pilia, P.: Altered villus vessel fibronectin in preeclampsia. Am. J. Obstet. Gynecol. 156:898–900, 1987.PubMedGoogle Scholar
  16. Attwood, H.D., and Park, W.W.: Embolism to the lungs by trophoblast. J. Obstet. Gynaecol. Br. Commonw. 68:611–617, 1961.PubMedCrossRefGoogle Scholar
  17. Ayala, A.R., De La Fuente, F.R., Loyola, F.D., Gonzalez, E., and Kunhardt, J.: Evidence that a toxemia-related organism (Hydatoxi lualba) is an artifact. Obstet. Gynecol. 67:47–50, 1086.Google Scholar
  18. Balasch, J., Mirapeix, E., Borche, L., Vives, J., and Gonzalez-Merlo, J.: Further evidence against preeclampsia as an immune complex disease. Obstet. Gynecol. 58:435–437, 1981.PubMedGoogle Scholar
  19. Bardawil, W.A., and Toy, B.L.: The natural history of choriocarcinoma: problems of immunity and spontaneous regression. Ann. N.Y. Acad. Sci. 80:197–261, 1959.PubMedCrossRefGoogle Scholar
  20. Bartholomew, R.A.: Hemorrhages of late pregnancy: with emphasis on placental circulation and the mechanism of bleeding. Postgrad. Med. 30:397–406, 1961.PubMedGoogle Scholar
  21. Bartholomew, R.A., Colvin, E.D., Grimes, W.H., Fish, J.S., Lester, W.M., and Galloway, W.H.: Facts pertinent to the etiology of eclamptogenic toxemia. Am. J. Obstet. Gynecol. 74:64–84, 1957.PubMedGoogle Scholar
  22. Bartholomew, R.A., Colvin, E.D., Grimes, W.H., Fish, J.S., Lester, W.M., and Galloway, W.H.: Criteria by which toxemia of pregnancy may be diagnosed from unlabeled formalin-fixed placentas. Am. J. Obstet. Gynecol. 82:277–290, 1961.PubMedGoogle Scholar
  23. Beaufils, M., Uzan, S., Donsimoni, R., and Colau, J.C.: Prevention of preeclampsia by early antiplatelet therapy. Lancet 1:840–842, 1985.PubMedCrossRefGoogle Scholar
  24. Benigni, A., Gregorini, G., Frusca, T., Chiabrando, C., Ballerini, S., Valcamonico, A., Orisio, S., Piccinelli, A., Pinciroli, V., Fanelli, R., Gastaldi, A., and Remuzzi, G.: Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N. Engl. J. Med. 321:357–362, 1989.PubMedCrossRefGoogle Scholar
  25. Benirschke, K., and Gille, J.: Placental pathology and asphyxia. In, Intrauterine Asphyxia and the Developing Fetal Brain. L. Gluck, ed. Year Book Medical Publishers, Chicago, 1977.Google Scholar
  26. Birkeland, S.A., and Kristofferson, K.: Preeclampsia-a state of mother-fetus immune imbalance. Lancet 2:720–723, 1979.PubMedCrossRefGoogle Scholar
  27. Bleyl, U., and Busing, C.M.: Disseminierte intravasale Gerinnung und perinataler Schock. Verh. Dtsch. Ges. Pathol. 53:495–501, 1969.PubMedGoogle Scholar
  28. Boe, F.: Vascular changes in premature separation of the normally implanted placenta. Acta Obstet. Gynecol. Scand. 38:441–443, 1951.CrossRefGoogle Scholar
  29. Branch, D.W., Andres, R., Digre, K.B., Rote, N.S., and Scott, J.R.: The association of antiphospholipid antibodies with severe preeclampsia. Obstet. Gynecol. 73:541–545, 1989.PubMedGoogle Scholar
  30. Brosens, I., and Renaer, M.: On the pathogenesis of placental infarcts in preeclampsia. J. Obstet. Gynaecol. Br. Commonw. 79:794–799, 1972.PubMedCrossRefGoogle Scholar
  31. Brosens, I., Robertson, W.B., and Dixon, H.G.: The physiological response of the vessels of the placental bed to normal pregnancy. J. Pathol. Bacteriol. 93: 569–579, 1967.PubMedCrossRefGoogle Scholar
  32. Brosens, I., Dixon, H.G., and Robertson, W.B.: Prostaglandins and preeclampsia. Lancet 2:412–413, 1974.PubMedCrossRefGoogle Scholar
  33. Budliger, H.: Plazentarveränderungen und ihre Beziehung zur Spättoxikose und perinatalen kindlichen Sterblichkeit. Fortschr. Geburtshilfe Gynäkol. 17:86–110, 1964.Google Scholar
  34. Cameron, H.M., and Park, W.W.: Decidual tissue within the lung. J. Obstet. Gynaecol. Br. Commonw. 72:748–754, 1965.PubMedCrossRefGoogle Scholar
  35. Cardwell, M.S.: Ultrasound diagnosis of abruptio placentae with fetomaternal hemorrhage. Am. J. Obstet. Gynecol. 157:358–359, 1987.PubMedGoogle Scholar
  36. Carter, B.: Premature separation of the normally implanted placenta: six deaths due to gross bilateral cortical necrosis of the kidneys. Obstet. Gynecol. 29: 30–33, 1967.PubMedGoogle Scholar
  37. Carter, J.E., Vellios, F., and Huber, C.P.: Histologic classification and incidence of circulatory lesions of the human placenta, with a review of the literature. Am. J. Clin. Pathol. 40:374–378, 1963a.Google Scholar
  38. Carter, J.E., Vellios, F., and Huber, C.P.: Circulatory factors governing the viability of the human placenta, based on a morphologic study. Am. J. Clin. Pathol. 40:363–373, 1963b.PubMedGoogle Scholar
  39. Cavanagh, D., Rao, P.S., Tung, K.S.K., and Gaston, L.: Eclamptogenic toxemia: The development of an experimental model in the subhuman primate. Am. J. Obstet. Gynecol. 120:183–196, 1974.PubMedGoogle Scholar
  40. Cavanagh, D., Rao, P.S., Tsai, C.C., and O’Connor, T.C.: Experimental toxemia in the pregnant primate. Am. J. Obstet. Gynecol. 128:75–85, 1977.PubMedGoogle Scholar
  41. Cavanagh, D., Rao, P.S., Knüppel, R.A., Desai, U., and Balis, J.U.: Pregnancy-induced hypertension: development of a model in the pregnant primate (Papio anubis). Am. J. Obstet. Gynecol. 151:987–999, 1985.PubMedGoogle Scholar
  42. Chalmers, I.: Salt, pregnancy, hypertension—and literature searches. Lancet 2:1146, 1988.PubMedCrossRefGoogle Scholar
  43. Chesley, L.C.: Diagnosis of preeclampsia. Obstet. Gynecol. 65:423–425, 1985.PubMedGoogle Scholar
  44. Cibils, L. A.: The placenta and newborn infant in hypertensive conditions. Am. J. Obstet. Gynecol. 118:256–268, 1974.PubMedGoogle Scholar
  45. Coen, R.W., Papile, L.-A., Figueroa, R., and Henderson, V.M.: Infant survival following protracted fetoplacental separation. Pediatrics 53:760–761, 1974.PubMedGoogle Scholar
  46. Covone, A.E., Mutton, D., Johnson, P.M., and Adi-nolfi, M.: Trophoblast cells in peripheral blood from pregnant women. Lancet 2:841–843, 1984.PubMedCrossRefGoogle Scholar
  47. Cunningham, F.G., Lowe, T., Guss, S., and Mason, R.: Erythrocyte morphology in women with severe preeclampsia: preliminary observations with scanning electron microscopy. Am. J. Obstet. Gynecol. 153: 358–363, 1985.PubMedGoogle Scholar
  48. Davey, D.A., and MacGillivray, I.: The classification and definition of the hypertensive disorders of pregnancy. Am. J. Obstet. Gynecol. 158:892–898, 1988.PubMedGoogle Scholar
  49. Davey, D.A., and MacGillivray, I.: Classification of hypertensive disorders of pregnancy. Lancet 2:112, 1989.CrossRefGoogle Scholar
  50. De Wolf, F., Robertson, W.B., and Brosens, I.: The ultrastructure of acute atherosis in hypertensive pregnancy. Am. J. Obstet. Gynecol. 123:164–174, 1975.PubMedGoogle Scholar
  51. Demers, L.M., and Gabbe, S.G.: Placental prostaglandin levels in preeclampsia. Am. J. Obstet. Gynecol. 126:137–139, 1976.PubMedGoogle Scholar
  52. Ducey, J., Schulman, H., Farmakides, G., Rochelson, B., Bracero, L., Fleischer, A., Guzman, E., Winter, D., and Penny, B.: A classification of hypertension in pregnancy based on Doppler velocimetry. Am. J. Obstet. Gynecol. 157:680–685, 1987.PubMedGoogle Scholar
  53. Dunlop, W., Hill, L.M., Landon, M.J., Oxley, A., and Jones, P.: Clinical relevance of coagulation and renal changes in preeclampsia. Lancet 2:346–349, 1978.PubMedCrossRefGoogle Scholar
  54. Dyer, I., and McCaughey, E.V.: Abruptio placentae: a ten-year survey. Am. J. Obstet. Gynecol. 77:1176–1184, 1959.PubMedGoogle Scholar
  55. Easterling, T.R., and Benedetti, T.J.: Preeclampsia: a hyperdynamic disease model. Am. J. Obstet. Gynecol. 160:1447–1453, 1989.PubMedCrossRefGoogle Scholar
  56. Edson, J.R., Blaese, R.M., White, J.G., and Krivit, W.: Defibrination syndrome in an infant born after abruptio placentae. Am. J. Obstet. Gynecol. 72:342–346, 1968.Google Scholar
  57. Epstein, F.H.: Late vascular effects of toxemia of pregnancy. N. Engl. J. Med. 271:391–395, 1964.PubMedCrossRefGoogle Scholar
  58. Erskine, K.J., Iversen, S.A., and Davies, R.: An altered ratio of 18:2(9,11) to 18:2(9,12) linoleic acid in plasma phospholipids as a possible predictor of preeclampsia. Lancet 1:554–555, 1985.PubMedCrossRefGoogle Scholar
  59. Fitzgerald, D.J., Rocki, W., Murray, R., Mayo, G., and Fitzgerald, G.A.: Thromboxane A2 synthesis in pregnancy-induced hypertension. Lancet 335:751–754, 1990.PubMedCrossRefGoogle Scholar
  60. Fox, H.: White infarcts of the placenta. J. Obstet. Gynaecol. Br. Commonw. 70:980–991, 1963.PubMedCrossRefGoogle Scholar
  61. Fox, H.: Effect of hypoxia on trophoblast in organ culture. Am. J. Obstet. Gynecol. 107:1058–1064, 1970.PubMedGoogle Scholar
  62. Friedman, S.A.: Preeclampsia: A review of the role of prostaglandins. Obstet. Gynecol. 71:122–137, 1988.PubMedGoogle Scholar
  63. Gau, G.S., Bhundia, J., Napier, K., and Ryder, T.A.: The worm that wasn’t. Lancet 1:1160–1161, 1983.PubMedCrossRefGoogle Scholar
  64. Gerretsen, G., Huisjes, H.J., and Elema, J.D.: Morphological changes of the spiral arteries in the placental bed in relation to preeclampsia and fetal growth retardation. Br. J. Obstet. Gynaecol. 88:876–881, 1981.PubMedCrossRefGoogle Scholar
  65. Gerretsen, G., Huisjes, H.J., Hardonk, M.J., and Elema, J.D.: Trophoblastic alterations in the placental bed in relation to physiological changes in spiral arteries. Br. J. Obstet. Gynaecol. 90:34–39, 1983.PubMedCrossRefGoogle Scholar
  66. Giles, W.B., Trudinger, B.J., and Baird, P.J.: Fetal umbilical artery blood flow velocity waveforms and placental resistance: pathological correlation. Br. J. Obstet. Gynaecol. 92:31–35, 1985.PubMedCrossRefGoogle Scholar
  67. Gille, J.H., Moore, D.G., and Sedgwick, C.J.: Placental infarction: a sign of preeclampsia in a Patas monkey (Erythrocebus patas). Lab. Anim. Sci. 27:120–121, 1977.Google Scholar
  68. Ginsburg, J., and Jeacock, M.K.: Placental lactate production in toxemia of pregnancy. Am. J. Obstet. Gynecol. 98:239–244, 1967.PubMedGoogle Scholar
  69. Griffin, J.F.T., and Wilson, E.W.: Preeclampsia: a state of mother-fetus immune imbalance. Lancet 2:1366–1367, 1979.PubMedCrossRefGoogle Scholar
  70. Grossman, R.A., and Goldberg, E.H.: Incidence and recurrence rate of abruptio placentae in Sweden. Obstet. Gynecol. 69:280–281, 1987.PubMedGoogle Scholar
  71. Gruenwald, P., Levin, H., and Yousem, H.: Abruption and premature separation of the placenta. Am. J. Obstet. Gynecol. 102:604–610, 1968.PubMedGoogle Scholar
  72. Gusdon, J.P., Heise, E.R., and Herbst, G.A.: Studies of lymphocyte populations in preeclampsia-eclampsia. Am. J. Obstet. Gynecol. 129:255–259, 1977.PubMedGoogle Scholar
  73. Gusdon, J.P., Heise, E.R., Quinn, K.J., and Matthews, L.C.: Lymphocyte subpopulations in normal and preeclampsia pregnancies. Am. J. Reprod. Immunol. 5:28–31, 1984.PubMedCrossRefGoogle Scholar
  74. Haile, H.: Über Schädigung des Neugeborenen bei Eklampsie. Z. Geburtshilfe Gynäkol. 120:334–352, 1940.Google Scholar
  75. Halberstadt, E., Schneider, D., and Gerber, E.: über die vorzeitige Lösung der normal inserierten Placenta. Gynaecologia 167:491–502, 1969.PubMedGoogle Scholar
  76. Hanretty, K.P., Whittle, M J., and Rubin, P.C.: Doppler uteroplacental waveforms in pregnancy-induced hypertension: a re-appraisal. Lancet 1:850–852, 1988.PubMedCrossRefGoogle Scholar
  77. Harris, B.A., Gore, H., and Flowers, C.E.: Peripheral placental separation: a possible relationship to premature labor. Obstet. Gynecol. 66:774–778, 1985.PubMedGoogle Scholar
  78. Haupt, H.: Über das Schocksyndrom des Neugeborenen nach vorzeitiger Plazentalösung. Münch. Med. Wochenschr. 105:441–449, 1963.PubMedGoogle Scholar
  79. Haust, M.D., Heras, I.L., and Harding, P.G.: Fat-containing uterine smooth muscle cells in “toxemia”: possible relevance to atherosclerosis? Science 195: 1353–1354,1977.PubMedCrossRefGoogle Scholar
  80. Haynes, D.M.: Experimental abruptio placentae in the rabbit. Am. I Obstet. Gynecol. 85:626–645, 1963.Google Scholar
  81. Hertig, A.T.: Vascular pathology in hypertensive albuminuric toxemias of pregnancy. Clinics 4:602–614, 1945.Google Scholar
  82. Hibbard, B.M., and Hibbard, E.D.: Aetiological factors in abruptio placentae. Br. Med. I 2:1430–1436, 1963.CrossRefGoogle Scholar
  83. Higgins, S.D., and Garite, T.J.: Late abruptio placenta in trauma patients: implications for monitoring. Obstet. Gynecol. 63:10S–12S, 1984.Google Scholar
  84. Hill, J.G., and Brunton, F.I: Artériographie assessment of placental vascularity after antepartum haemorrhage. Br. Med. I 1:25–26, 1968.CrossRefGoogle Scholar
  85. Hodari, A.A.: Chronic uterine ischemia and reversible experimental “toxemia of pregnancy.” Am. J. Obstet. Gynecol. 97:597–607, 1967.PubMedGoogle Scholar
  86. Hoff, G., and Bixler, G.: Maternofetal ABO antigenic dissimilarity and preeclampsia. Lancet 1:729–730, 1984.PubMedCrossRefGoogle Scholar
  87. Hollister, M.G., Reid, D.L., Phernetton, T.M., Landauer, M., and Rankin, J.H.G.: Dose-response curves of the uterine and placental vascular beds to prostaglandin I2. Am. I Obstet. Gynecol. 159:1372–1375, 1988.Google Scholar
  88. Holmes, R.W.: Ablatio placentae. J.A.M.A. 51:1845–1848, 1908.CrossRefGoogle Scholar
  89. Hölzl, M., Lüthje, D., and Seck-Ebersbach, K.: Piacentaveränderungen bei EPH-Gestose: morphologischer Befund und Schweregrad der Erkrankung. Arch. Gynäkol. 217:315–334, 1974.PubMedCrossRefGoogle Scholar
  90. Houwert-De Jong, M.H., te Velde, E.R., Nefkens, M.J.J., and Schuurman, H.J.: Immune complexes in skin of patients with pre-eclamptic toxaemia. Lancet 2:387, 1982.CrossRefGoogle Scholar
  91. Howard, B.K., and Goodson, J.H.: Experimental placental abruption. Obstet. Gynecol. 2:442–446, 1953.PubMedGoogle Scholar
  92. Howard, R.B., Hosokawa, T., and Maguire, M.H.: Hypoxia-induced fetoplacental vasoconstriction in perfused human placental cotyledons. Am. J. Obstet. Gynecol. 157:1261–1266, 1987.PubMedGoogle Scholar
  93. Huber, C.P., Carter, I.E., and Vellios, F.: Lesions of the circulatory system of the placenta: a study of 234 placentas with special reference to the development of infarcts. Am. J. Obstet. Gynecol. 81:560–573, 1961.PubMedGoogle Scholar
  94. Hulka, J.F., and Brinton, V.: Antibody to trophoblast during early postpartum period in toxemic pregnancies. Am. J. Obstet. Gynecol. 86:130–134, 1963.PubMedGoogle Scholar
  95. Hunter, C.A., Howard, W.F., and McCormick, C.O: Postpartum curettage effective in reducing hypertension of toxemia. Am. J. Obstet. Gynecol. 81:884–889, 1961.PubMedGoogle Scholar
  96. Iklé, A.: Trophoblastzellen im strömenden Blut. Schweiz. Med. Wochenschr. 91:943, 1961.PubMedGoogle Scholar
  97. Iklé, F.A.: Dissemination von Syncytiotrophoblast-zellen im mütterlichen Blut während der Gravidität. Bull. Schweiz. Akad. Med. Wiss. 20:63–72, 1964.Google Scholar
  98. Jäämeri, K.E.U., Koivuniemi, A.P., and Carpén, E.O.: Occurrence of trophoblasts in the blood of toxaemic patients. Gynaecologia 160:315–320, 1965.PubMedGoogle Scholar
  99. Javert, C.T., and Reiss, C.: The origin and significance of macroscopic intervillous coagulation hematomas (red infarcts) of the human placenta. Surg. Gynecol. Obstet. 94:257–269, 1952.Google Scholar
  100. Jeremy, J.Y., Barradas, M.A., Mikhailidis, D.P., and Dandona, P.: Placental prostacyclin production in normal and toxemic pregnancies. Am. J. Obstet. Gynecol. 154:212–213, 1986.PubMedGoogle Scholar
  101. Jones, C.J.P., and Fox, H.: An ultrastructural and ultra-histochemical study of the human placenta in maternal preeclampsia. Placenta 1:61–76, 1980.PubMedCrossRefGoogle Scholar
  102. Kâregèrd, M., and Gennser, G.: Incidence and recurrence rate of abruptio placentae in Sweden. Obstet. Gynecol. 67:523–528, 1986.Google Scholar
  103. Khong, T.Y.: Immunohistologic study of the leukocytic infiltrate in maternal uterine tissues in normal and preeclamptic pregnancies at term. Am. J. Reprod. Immunol. 15:1–8, 1987.Google Scholar
  104. Khong, T.Y., Pearce, J.M., and Robertson, W.B.: Acute atherosis in preeclampsia: Maternal determinants and fetal outcome in the presence of the lesion. Am. J. Obstet. Gynecol. 157:360–363, 1987.PubMedGoogle Scholar
  105. Kilpatrick, D.C.: Immune mechanisms and preeclampsia. Lancet 2:1460–1461, 1987.PubMedCrossRefGoogle Scholar
  106. Kitzmiller, J.L., and Benirschke, K.: Immunofluores-cent study of placental bed vessels in preeclampsia of pregnancy. Am. J. Obstet. Gynecol. 115:248–251, 1973.PubMedGoogle Scholar
  107. Kitzmiller, J.L., Stoneburner, L., Yelenovsky, P.F., and Lucas, W.E.: Serum complement in normal pregnancy and preeclampsia. Am. J. Obstet. Gynecol. 117:312–315, 1973.PubMedGoogle Scholar
  108. Kitzmiller, J.L., Watt, N., and Driscoll, S.G.: Decidual arteriopathy in hypertension and diabetes in pregnancy: immunofluorescent studies. Am. J. Obstet. Gynecol. 141:773–778, 1981.PubMedGoogle Scholar
  109. Klurfeld, D.M.: Identification of foam cells in human atherosclerotic lesions as macrophages using monoclonal antibodies. Arch. Pathol. 109:445–449, 1985.Google Scholar
  110. Knox, G.E., Stagno, S., Volanakis, J.E., and Huddleston, J.F.: A search for antigen-antibody complexes in preeclampsia: further evidence against immunologic pathogenesis. Am. J. Obstet. Gynecol. 132:87–89, 1978.PubMedGoogle Scholar
  111. König, P.A.: Über Eklampsietod und Gefäßwandschaden bei Mutter und Kind. Z. Geburtshilfe Gynäkol. 146:292–307, 1956.PubMedGoogle Scholar
  112. Labarrere, C.A.: Placental bed biopsy technique and vascular changes. Am. J. Obstet. Gynecol. 157:1320–1322, 1987.PubMedGoogle Scholar
  113. Lau, H., Sackreuther, W., Bach, H.G., Grabber, W., and Hundertmarck, R.: Über die vorzeitige Lösung der normal sitzenden Placenta: klinische Beobachtungen an 100 Fällen. Gynaecologia 157:143–160, 1964.PubMedGoogle Scholar
  114. Lemtis, H.: Über die vorzeitige Lösung der normal sitzenden Plazenta. Forsch. Praxis Fortbildung 18: 231–237, 1967.Google Scholar
  115. Lichtig, C., Deutsch, M., and Brandes, J.: Vascular changes of endometrium in early pregnancy. Am. J. Clin. Pathol. 81:702–707, 1984.PubMedGoogle Scholar
  116. Lilford, R.J.: Classification of hypertensive disorders of pregnancy. Lancet 2:112–113, 1989.Google Scholar
  117. Long, E.G., Tsin, T.Y., Reinarz, J.A., Schnadig, V.J., McLucas, E., and Kelly, R.T.: “Hydatoxi lualba” identified. Am. J. Obstet. Gynecol. 149:462–463, 1984.PubMedGoogle Scholar
  118. Lueck, J., Brewer, J.I., Aladjem, S., and Novotny, M.: Observation of an organism found in patients with gestational trophoblastic disease and in patients with toxemia of pregnancy. Am. J. Obstet. Gynecol. 145: 15–26, 1983.PubMedGoogle Scholar
  119. Lundberg, C., Marceau, F., Huey, P., and Hugh, T.E.: Anaphylatoxin C5a fails to promote prostacyclin release in cultured endothelial cells from human umbilical veins. Immunopharmacology 12:135–143, 1986.PubMedCrossRefGoogle Scholar
  120. MacLennan, A.H., Sharp, F., and Shaw-Dunn, J.: The ultrastructure of human trophoblast in spontaneous and induced hypoxia using a system of organ culture: a comparison with ultrastructural changes in preeclampsia and placental insufficiency. J. Obstet. Gynaecol. Br. Commonw. 79:113–121, 1972.CrossRefGoogle Scholar
  121. Mäkilä, U.-M., Viinikka, L., and Ylikorkala, Q: Evidence that prostacyclin deficiency is a specific feature in preeclampsia. Am. J. Obstet. Gynecol. 148:772–774, 1984.PubMedGoogle Scholar
  122. Mäkilä, U.-M., Jouppila, P., Kirkinen, P., Viinikka, L., and Ylkorkala, O.: Placental thromboxane and prostacyclin in the regulation of placental blood flow. Obstet. Gynecol. 68:537–540, 1986.PubMedGoogle Scholar
  123. Marais, W.D.: Human decidual spiral arterial studies. Part II. A universal thesis on the pathogenesis of intraplacental fibrin deposits, layered thrombosis, red and white infarcts and toxic and non-toxic abruptio placentae: a microscopic study. J. Obstet. Gynaecol. Br. Commonw. 69:213–224, 1962a.CrossRefGoogle Scholar
  124. Marais, W.D.: Human decidual spiral arterial studies. Part III. Histological patterns and some clinical implications of decidual spiral arteriosclerosis. J. Obstet. Gynaecol. Br. Commonw. 69:225–233, 1962b.CrossRefGoogle Scholar
  125. Marais, W.D.: Human decidual spiral arterial studies. Part V. Pathogenetic patterns of intraplacental lesions. J. Obstet. Gynaecol. Br. Commonw. 69:944–955, 1962c.CrossRefGoogle Scholar
  126. Marais, W.D.: Human decidual spiral arterial studies. Part VI. Postmortem circulation studies on an in situ placenta. S. Afr. Med. J. 36:678–681, 1962d.PubMedGoogle Scholar
  127. Marais, W.D.: Human decidual spiral arterial studies. Part VII. The clinical evaluation of normal and abnormal spiral arterioles and of placental lesions: a statistical study. J. Obstet. Gynaecol. 70:777–786, 1963a.CrossRefGoogle Scholar
  128. Marais, W.D.: Human decidual spiral arterial studies. Part VIII. The aetiological relationship between toxaemia-hypertension of pregnancy and spiral arterial placental pathology. S. Afr. Med. J. 37:117–120, 1963b.PubMedGoogle Scholar
  129. Marcuse, P.M.: Pulmonary syncytial giant cell embolism: report of maternal death. Obstet. Gynecol. 3: 210–213, 1954.PubMedGoogle Scholar
  130. Massobrio, M., Benedetto, C., Bertini, E., Tetta, C., and Camussi, G.: Immune complexes in preeclampsia and normal pregnancy. Am. J. Obstet. Gynecol. 152: 578–583, 1985.PubMedGoogle Scholar
  131. Maymon, R., Bahari, C., and Moroz, C.: Placental isoferritin: a new serum marker in toxemia of pregnancy. Am. J. Obstet. Gynecol. 160:681–684, 1989.PubMedCrossRefGoogle Scholar
  132. McFayden, LR., Price, A.B., and Geirsson, R.T.: The relation of birthweight to histological appearances in vessels of the placental bed. Br. J. Obstet. Gynaecol. 93:476–481, 1986.Google Scholar
  133. McKay, D.G., Jewett, J.F., and Reid, D.E.: Endotoxin shock and the generalized Shwartzman reaction in pregnancy. Am. J. Obstet. Gynecol. 78:546–566, 1959.Google Scholar
  134. McLaughlin, P.J., Stirrat, G.M., Redman, C.W.G., and Levinsky, R.J.: Immune complexes in normal and preeclamptic pregnancy. Lancet 1:934–935, 1979.PubMedCrossRefGoogle Scholar
  135. Mirro, R., and Brown, D.R.: Edema, proteinuria, thrombocytopenia, and leukopenia in infants of preeclamptic mothers. Am. J. Obstet. Gynecol. 144: 851–852, 1982.PubMedGoogle Scholar
  136. Müller, G., Philippe, E., Lefakis, P., de Mot-Leclair, M., Dreyfus, J., Nusynowicz, G., Renaud, R., and Gandar, R.: Les lésions placentaires de la gestose: étude anatomo-clinique. Gynecol. Obstet. 70:309–316, 1971.Google Scholar
  137. Musci, T.J., Roberts, J.M., Rodgers, G.M., and Taylor, R.N.: Mitogenic activity is increased in the sera of preeclamptic women before birth. Am. J. Obstet. Gynecol. 159:1446–1451, 1988.PubMedGoogle Scholar
  138. Myers, R.E., and Fujikura, T.: Placental changes after experimental abruptio placentae and fetal vessel ligation of rhesus monkey placenta. Am. J. Obstet. Gynecol. 100:846–851, 1968.Google Scholar
  139. Nadji, P., and Sommers, S.C.: Lesions of toxemia in first trimester pregnancies. Am. J. Clin. Pathol. 59:344–349, 1973.PubMedGoogle Scholar
  140. Naeye, R.L.: Placental infarction leading to fetal or neonatal death. A prospective study. Obstet. Gynecol. 50:583–588, 1977.PubMedGoogle Scholar
  141. Naeye, R.L., Harkness, W.L., and Utts, J.: Abruptio placentae and perinatal death: A prospective study. Am. J. Obstet. Gynecol. 128:740–746, 1977.PubMedGoogle Scholar
  142. Ness, P.M., Budzynski, A.Z., Olexa, S.A., and Rod-vien, R.: Congenital hypofibrinogenemia and recurrent placental abruption. Obstet. Gynecol. 61:519–523, 1983.PubMedGoogle Scholar
  143. Niswander, R.K., and Gordon, M.: The Women and their Pregnancies, p. 43. Saunders, Philadelphia, 1972.Google Scholar
  144. Notelvitz, M., Bottoms, S.F., Dase, D.F., and Leichter, P.J.: Painless abruptio placentae. Obstet. Gynecol. 53:270–272, 1979.Google Scholar
  145. O’Brien, W.F., Knüppel, R.A., Saba, H.I., Angel, J.L., Benoit, R., and Bruce, A.: Platelet inhibitory activity in placentas from normal and abnormal pregnancies. Obstet. Gynecol. 70:597–600, 1987.PubMedGoogle Scholar
  146. O’Brien, W.F., Knüppel, R.A., Saba, H.I., Angel, J.L., Benoit, R., and Bruce, A.: Serum prostacyclin binding and half-life in normal and hypertensive pregnant women. Obstet. Gynecol. 73:43–46, 1988.Google Scholar
  147. Palmer, A.E., London, W.T., Sly, D.L., and Rice, J.M.: Toxemia of pregnancy (preeclampsia, eclampsia, hypertensive disorders of pregnancy). In, Spontaneous Animal Models of Human Disease. Vol. I. E.J.Google Scholar
  148. Andrews, B.C. Ward, and N.H. Altman, eds., pp. 213–215. Academic Press, Orlando, 1979.Google Scholar
  149. Pavelka, M., Pavelka, R., and Gerstner, G.: Ultrastructure of the syncytiotrophoblast of the human term placenta in EPH-gestosis. Gynecol. Obstet. Invest. 10:177–185, 1979.PubMedCrossRefGoogle Scholar
  150. Pearce, J.M., and McParland, P.: Doppler uteroplacental waveforms. Lancet 1:1287–1288, 1988.CrossRefGoogle Scholar
  151. Pittard III, W.B., Schleich, D.M., Geddes, K.M., and Sorensen, R.U.: Newborn lymphocyte subpopulations: The influence of labor. Am. J. Obstet. Gynecol. 160:151–154, 1989.PubMedCrossRefGoogle Scholar
  152. Pober, J.S.: Cytokine-mediated activation of vascular endothelium: physiology and pathology. Am. J. Pathol. 133:426–433, 1988.PubMedGoogle Scholar
  153. Rappaport, V.J., Hirata, G., Yap, H.K., and Jordan, S.C.: Anti-vascular endothelial cell antibodies in severe preeclampsia. Am. J. Obstet. Gynecol. 162: 138–146, 1990.PubMedCrossRefGoogle Scholar
  154. Rauramo, I., and Forss, M.: Effect of exercise on placental blood flow in pregnancies complicated by hypertension, diabetes or intrahepatic cholestasis. Acta Obstet. Gynecol. Scand. 67:15–20, 1988.CrossRefGoogle Scholar
  155. Redman, C.W.G., and Jefferies, M.: Revised definition of preeclampsia. Lancet 1:809–812, 1988.PubMedCrossRefGoogle Scholar
  156. Redman, C.W.G., Bodmer, J.G., Bodmer, W.F., Beilin, L.J., and Bonnar, J.: HLA antigens in severe preeclampsia. Lancet 2:397–399, 1978.PubMedCrossRefGoogle Scholar
  157. Robbins, P.G., Gorbach, A.G., and Reid, D.E.: Neurologic abnormalities at one year in infants delivered after late-pregnancy hemorrhage. Obstet. Gynecol. 29:358–361, 1967.PubMedGoogle Scholar
  158. Roberts, J.M.: Classification of hypertensive disorders of pregnancy. Lancet 2:112, 1989.Google Scholar
  159. Robertson, W.B., Brosens, I., and Dixon, H.G.: The pathological response of the vessels of the placental bed to hypertensive pregnancy. J. Pathol. Bacteriol. 93:581–592, 1967.PubMedCrossRefGoogle Scholar
  160. Robertson, W.B., Khong, T.Y., Brosens, I., De Wolf, F., Sheppard, B.L., and Bonnar, J.: The placental bed biopsy: review from three European centers. Am. J. Obstet. Gynecol. 155:401–412, 1986.PubMedGoogle Scholar
  161. Robinson, M.: Salt in pregnancy. Lancet 1:178–181, 1958.PubMedCrossRefGoogle Scholar
  162. Roffman, B.Y., and Simons, M.: Syncytial trophoblastic embolism associated with placenta increta and preeclampsia. Am. J. Obstet. Gynecol. 104:1218–1220, 1969.PubMedGoogle Scholar
  163. Rosenfeld, C.R.: Preeclampsia: a review of the role of prostaglandins. Obstet. Gynecol. 72:284–285, 1988.PubMedGoogle Scholar
  164. Rote, N.S., and Caudle, M.R.: Circulating immune complexes in pregnancy, preeclampsia, and autoimmune diseases: evaluation of Raji cell enzyme-linked immunosorbent assay and polyethylene glycol precipitation methods. Am. J. Obstet. Gynecol. 147:267–273, 1983.PubMedGoogle Scholar
  165. Rushton, D.I.: Trophoblast cells in peripheral blood. Lancet 2:1153–1154, 1984.PubMedCrossRefGoogle Scholar
  166. Sanerkin, N.G., and Evans, D.M.D.: Bilateral renal cortical necrosis in infants, associated with maternal antepartum haemorrhage. J. Pathol. Bacteriol. 90: 269–274, 1965.PubMedCrossRefGoogle Scholar
  167. Schaffner, T., Taylor, K., Bartucci, E.J., Fischer-Dzoga, K., Beeson, J.H., Glagov, S., and Wissler, R.W.: Arterial foam cells with distinctive immunomorpho-logic and histochemical features of macrophages. Am. J. Pathol. 100:57–80, 1980.PubMedGoogle Scholar
  168. Schiff, E., Peleg, E., Goldenberg, M., Rosenthal, T., Ruppin, E., Tamarkin, M., Barkai, G., Ben-Baruch, G., Yahal, I., Blankstein, J., Goldman, B., and Mash-iach, S.: The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N. Engl. J. Med. 321:351–356, 1989.PubMedCrossRefGoogle Scholar
  169. Schmidt, B.K., Muraji, T., and Zipursky, A.: Low anti-thrombin III in neonatal shock: DIC or non-specific protein depletion? Eur. J. Pediatr. 145:500–503, 1986.PubMedCrossRefGoogle Scholar
  170. Schmorl, G.: Pathologisch-Anatomische Untersuchungen über Puerperale Eklampsie. Vogel, Leipzig, 1893.Google Scholar
  171. Schneider, C.L.: “Fibrin embolism” (disseminated intravascular coagulation) with defibrination as one of the end results during placenta abruptio. Surg. Gynecol. Obstet. 92:27–34, 1951.Google Scholar
  172. Schneider, C.L.: Abruptio placentae after fetal death in utero. Obstet. Gynecol. 1:321–326, 1953.PubMedGoogle Scholar
  173. Schuhmann, R., and Geier, G.: Histomorphologische Placentabefunde bei EPH-Gestose: ein Beitrag zur Morphologie der insuffizienten Placenta. Arch. Gynäkol. 213:31–47, 1972.PubMedCrossRefGoogle Scholar
  174. Schuhmann, R., and Lehmann, W.D.: Beziehungen zwischen Placentamorphologie und biochemischen Befunden bei EPH-Gestose und Diabetes mellitus: Dehydroandrosteronbelastungstest, in vitro Umwandlungsrate von 4–14C-Dehydroepiandrosteron in Oestrogène, Oestrogenausscheidung im 24 Std-Urin. Arch. Gynäkol. 215:72–84, 1973.PubMedCrossRefGoogle Scholar
  175. Scott, J.R., and Beer, A.A.: Immunologie aspects of preeclampsia. Am. J. Obstet. Gynecol. 125:418–427, 1976.PubMedGoogle Scholar
  176. Scott, J.S., and Jenkins, D.M.: Review article: immuno-genetic factors in aetiology of preeclampsia/eclampsia (gestosis). J. Med. Genet. 13:200–207, 1976.PubMedCrossRefGoogle Scholar
  177. Scott, J.S., Jenkins, D.M., and Need, J.A.: Immunology of preeclampsia. Lancet 1:704–706, 1978.PubMedCrossRefGoogle Scholar
  178. Shanklin, D.R.: The human placenta with especial reference to infarction and toxemia. Obstet. Gynecol. 13:325–336, 1959.PubMedGoogle Scholar
  179. Shanklin, D.R., and Sibai, B.M.: Ultrastructural aspects of preeclampsia. I. Placental bed and uterine boundary vessels. Am. J. Obstet. Gynecol. 161:735–741, 1989.PubMedCrossRefGoogle Scholar
  180. Sholl, J.S.: Abruptio placentae: clinical management in nonacute cases. Am. J. Obstet. Gynecol. 156:40–51, 1987.PubMedGoogle Scholar
  181. Siegel, P.: Beziehungen zwischen eklamptischen Placen-tarveränderungen und intrauterinem Fruchttod. Fortschr. Med. 80:75–82, 1962.Google Scholar
  182. Soma, H., Yoshida, K., Mukaida, T., and Tabuchi, Y.: Morphologie changes in the hypertensive placenta. Contrib. Gynecol. Obstet. 9:58–75, 1982.Google Scholar
  183. Sophian, J.: Antibodies to trophoblast post partum and toxemia. Am. J. Obstet. Gynecol. 88:280–281, 1964.Google Scholar
  184. Sridama, V., Yang, S.L., Moawad, A., and De Groot, L.J.: T-cell subsets in patients with preeclampsia. Am. J. Obstet. Gynecol. 147:566–569, 1983.PubMedGoogle Scholar
  185. Stark, J., and Kaufmann, P.: Infarktgenese in der Placenta. Arch. Gynäkol. 217:189–208, 1974.PubMedCrossRefGoogle Scholar
  186. Steigrad, K.: Über die Beziehung von Plazentarinfarkten zur Schwangerschafts-Nephropathie: Zugleich ein Beitrag zur Pathologie der Plazenta. Gynaecologia 134:273–322, 1952.PubMedGoogle Scholar
  187. Stuart, M.J., Clark, D.A., Sunderji, S.G., Allen, J.B., Yambo, T., Elrad, H. and Slott, J.H.: Decreased prostacyclin production: a characteristic of chronic placental insufficiency syndromes. Lancet 1:1126–1128, 1981.PubMedCrossRefGoogle Scholar
  188. Tatum, H.J.: Placental abruption. Obstet. Gynecol. 2: 447–453, 1953.PubMedGoogle Scholar
  189. Teasdale, F.: Histomorphometry of the human placenta in maternal preeclampsia. Am. J. Obstet. Gynecol. 152:25–31, 1985.PubMedGoogle Scholar
  190. Tedeschi, L.G., and Tedeschi, C.G.: Experimental trophoblastic embolism and hyperplasminemia. Arch. Pathol. 76:387–397, 1963.PubMedGoogle Scholar
  191. Tenney, B., and Parker, F.: The placenta in toxemia of pregnancy. Am. J. Obstet. Gynecol. 39:1000–1005, 1940.Google Scholar
  192. Thorp, J.A., Walsh, S.W., and Brath, P.C.: Low-dose aspirin inhibits thromboxane, but not prostacyclin, production by human placental arteries. Am. J. Obstet. Gynecol. 159:1381–1384, 1988.PubMedGoogle Scholar
  193. Toder, V., Blank, M., Gleicher, N., Voljovich, I., Mashiah, S., and Nebel, L.: Activity of natural killer cells in normal pregnancy and edema-proteinuria-hypertension gestosis. Am. J. Obstet. Gynecol. 145: 7–10, 1983.PubMedGoogle Scholar
  194. Tominaga, T., and Page, E.W.: Accommodation of the human placenta to hypoxia. Am. J. Obstet. Gynecol. 84:679–691, 1966.Google Scholar
  195. Torpin, R., and Swain, B.: Placental infarction in 1,000 cases correlated with the clinical findings. Am. J. Obstet. Gynecol. 94:284–285, 1966.PubMedGoogle Scholar
  196. Vasquez-Escobosa, C., Perez-Medina, R., and Gomez-Estrada, H.: Circulating immune complexes in hypertensive disease of pregnancy. Obstet. Gynecol. 62: 45–48,1982.Google Scholar
  197. Vassalli, P., Morris, R.H., and McCluskey, R.T.: The pathogenic role of fibrin deposition in the glomerular lesions of toxemia of pregnancy. J. Exp. Med. 118: 467–478, 1963.PubMedCrossRefGoogle Scholar
  198. Waddington, H.K.: Fetal salvage in abruptio placentae. Am. J. Obstet. Gynecol. 73:812–816, 1957.Google Scholar
  199. Wagner, D.: Trophoblastic cells in the blood stream in normal and abnormal pregnancy. Acta Cytol. (Baltimore) 12:137–139, 1968.Google Scholar
  200. Wagner, D., Schunck, R., and Isebarth, H.: Der Nachweis von Trophoblastzellen im strömenden Blut der Frau bei normaler und gestörter Gravidität. Gynaecologia 158:175–192, 1964.PubMedGoogle Scholar
  201. Wallenburg, H.C.S.: Über den Zusammenhang zwischen Spätgestose und Placentarinfarkt. Arch. Gynäkol. 208:80–90, 1969.PubMedCrossRefGoogle Scholar
  202. Wallenburg, H.C.S., Stolte, L.A.M., and Janssens, J.: The pathogenesis of placental infarction. I. A morphologic study in the human placenta. Am. J. Obstet. Gynecol. 116:835–840, 1973a.PubMedGoogle Scholar
  203. Wallenburg, H.C.S., Hutchinson, D.L., Schüler, H.M., Stolte, L.A.M., and Janssens, J.: The pathogenesis of placental infarction. II. An experimental study in the rhesus monkey placenta. Am. J. Obstet. Gynecol. 116:841–846, 1973b.PubMedGoogle Scholar
  204. Walsh, S.W.: Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am. J. Obstet. Gynecol. 152:335–340, 1985.PubMedGoogle Scholar
  205. Walsh, S.W., Behr, M.J., and Allen, N.H.: Placental prostacyclin production in normal and toxemic pregnancies. Am. J. Obstet. Gynecol. 151:110–115, 1985.PubMedGoogle Scholar
  206. Weiner, C., and Keller, S.: Preeclampsia is not associated with excess fetal clotting. Obstet. Gynecol. 68: 871–872, 1986.PubMedGoogle Scholar
  207. Weir, P.E.: Immunofluorescent studies of the uteroplacental arteries in normal pregnancy. Br. J. Obstet. Gynaecol. 88:301–307, 1981.PubMedCrossRefGoogle Scholar
  208. Wells, M., and Bulmer, J.N.: The human placental bed: histology, immunohistochemistry and pathology. His-topathology 13:483–498, 1988.Google Scholar
  209. Wentworth, P.: Placental infarction and toxemia of pregnancy. Am. J. Obstet. Gynecol. 99:318–326, 1967.PubMedGoogle Scholar
  210. Wielenga, G., and Willighagen, R.G.J.: Histochemical investigation of ischemic villi in the placenta. Am. J. Obstet. Gynecol. 96:956–968, 1966.PubMedGoogle Scholar
  211. Willems, J.: The etiology of preeclampsia: a hypothesis. Obstet. Gynecol. 50:495–499, 1977.PubMedGoogle Scholar
  212. Wisot, A.L.: Silent abruptio placentae with marked hypofibrinogenemia. J.A.M.A. 207:557–558, 1969.PubMedCrossRefGoogle Scholar
  213. Wynn, R.M.: The placenta in preeclampsia. Obstet. Gynecol. Annu. 6:191–196, 1977.PubMedGoogle Scholar
  214. Ylikorkala, O. and Mäkilä, U.-M.: Prostacyclin and thromboxane in gynecology and obstetrics. Am. J. Obstet. Gynecol. 152:318–329, 1985.PubMedGoogle Scholar
  215. Zacks, S., and Blazar, A.S.: Chorionic villi in normal pregnancy, pre-eclamptic toxemia, erythroblastosis, and diabetes mellitus: a light- and electron-microscope study. Obstet. Gynecol. 22:149–167, 1963.PubMedGoogle Scholar
  216. Zeek, P.M., and Assali, N.S.: Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy. Am. J. Clin. Pathol. 20:1099–1109, 1950.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1990

Authors and Affiliations

  • Kurt Benirschke
    • 1
    • 2
  • Peter Kaufmann
    • 3
  1. 1.Pathology and Reproductive MedicineUniversity of CaliforniaSan DiegoUSA
  2. 2.University Medical CenterSan DiegoUSA
  3. 3.Institut für Anatomie der Medizinischen Fakultät, Rheinisch-Westfälische TechnischeHochschule AachenAachenGermany

Personalised recommendations